EXTAVIA for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where EXTAVIA was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for EXTAVIA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site erythema | 19 | 17.4% | 0 | 5 |
| Gait disturbance | 16 | 14.7% | 0 | 5 |
| Multiple sclerosis relapse | 13 | 11.9% | 0 | 3 |
| Fatigue | 12 | 11.0% | 0 | 4 |
| Injection site pain | 12 | 11.0% | 0 | 1 |
| Fall | 10 | 9.2% | 0 | 4 |
| Hypoaesthesia | 9 | 8.3% | 0 | 2 |
| Depression | 8 | 7.3% | 0 | 3 |
| Erythema | 8 | 7.3% | 0 | 2 |
| Influenza like illness | 8 | 7.3% | 0 | 2 |
| Multiple sclerosis | 8 | 7.3% | 0 | 3 |
| Paraesthesia | 8 | 7.3% | 0 | 4 |
| Balance disorder | 7 | 6.4% | 0 | 1 |
| Headache | 7 | 6.4% | 0 | 2 |
| Asthenia | 6 | 5.5% | 0 | 1 |
Other Indications for EXTAVIA
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)